{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:13:48Z","timestamp":1792826028253,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder that affects the skin and the nervous system. The condition is completely penetrant with extreme clinical variability, resulting in unpredictable manifestations in affected offspring, complicating reproductive decision-making. One of the reproductive options to prevent the birth of affected offspring is preimplantation genetic testing (PGT). We performed a retrospective review of the medical files of all couples (<jats:italic>n<\/jats:italic>\u2009=\u2009140) referred to the Dutch PGT expert center with the indication NF1 between January 1997 and January 2020. Of the couples considering PGT, 43 opted out and 15 were not eligible because of failure to identify the underlying genetic defect or unmet criteria for in vitro fertilization (IVF) treatment. The remaining 82 couples proceeded with PGT. Fertility assessment prior to IVF treatment showed a higher percentage of male infertility in males affected with NF1 compared to the partners of affected females. Cardiac evaluations in women with NF1 showed no contraindications for IVF treatment or pregnancy. For 67 couples, 143 PGT cycles were performed. Complications of IVF treatment were not more prevalent in affected females compared to partners of affected males. The transfer of 174 (out of 295) unaffected embryos led to 42 ongoing pregnancies with a pregnancy rate of 24.1% per embryo transfer. There are no documented cases of misdiagnosis following PGT in this cohort. With these results, we aim to provide an overview of PGT for NF1 with regard to success rate and safety, to optimize reproductive counseling and PGT treatment for NF1 patients.<\/jats:p>","DOI":"10.1038\/s41431-023-01404-x","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T07:02:41Z","timestamp":1687158161000},"page":"918-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Preimplantation genetic testing for Neurofibromatosis type 1: more than 20 years of clinical experience"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9820-8958","authenticated-orcid":false,"given":"Vivian","family":"Vernimmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1661-7625","authenticated-orcid":false,"given":"Aim\u00e9e D. C.","family":"Paulussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos C. F. M.","family":"Dreesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron J.","family":"van Golde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Zamani Esteki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-7369","authenticated-orcid":false,"given":"Edith","family":"Coonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne L.","family":"van Buul-van Zwet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Homminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alwin A. H. A.","family":"Derijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Brandts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance T. R. M.","family":"Stumpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E. M.","family":"de Die-Smulders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"key":"1404_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/B978-0-444-64076-5.00051-X","volume":"148","author":"PJ Cimino","year":"2018","unstructured":"Cimino PJ, Gutmann DH. Neurofibromatosis type 1. Handb Clin Neurol. 2018;148:799\u2013811.","journal-title":"Handb Clin Neurol"},{"key":"1404_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152a","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010;152a:327\u201332.","journal-title":"Am J Med Genet A"},{"key":"1404_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","volume":"89","author":"JM Friedman","year":"1999","unstructured":"Friedman JM. Epidemiology of neurofibromatosis type 1. Am J Med Genet. 1999;89:1\u20136.","journal-title":"Am J Med Genet"},{"key":"1404_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","volume":"12","author":"K Jett","year":"2010","unstructured":"Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2010;12:1\u201311.","journal-title":"Genet Med"},{"key":"1404_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-1310-3","volume":"15","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Servy A, Valeyrie-Allanore L, Ferkal S, Combemale P, Wolkenstein P. Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966. Orphanet J Rare Dis. 2020;15:37.","journal-title":"Orphanet J Rare Dis"},{"key":"1404_CR6","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/gim.2018.28","volume":"20","author":"DR Stewart","year":"2018","unstructured":"Stewart DR, Korf BR, Nathanson KL, Stevenson DA, Yohay K. Care of adults with neurofibromatosis type 1: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018;20:671\u201382.","journal-title":"Genet Med"},{"key":"1404_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1055\/s-0037-1620239","volume":"49","author":"C Barrea","year":"2018","unstructured":"Barrea C, Vaessen S, Bulk S, Harvengt J, Misson JP. Phenotype-genotype correlation in children with neurofibromatosis type 1. Neuropediatrics 2018;49:180\u20134.","journal-title":"Neuropediatrics"},{"key":"1404_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00439-017-1766-y","volume":"136","author":"H Kehrer-Sawatzki","year":"2017","unstructured":"Kehrer-Sawatzki H, Mautner VF, Cooper DN. Emerging genotype-phenotype relationships in patients with large NF1 deletions. Hum Genet. 2017;136:349\u201376.","journal-title":"Hum Genet"},{"key":"1404_CR9","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/ajmg.a.38680","volume":"176","author":"AB Rietman","year":"2018","unstructured":"Rietman AB, van Helden H, Both PH, Taal W, Legerstee JS, van Staa A, et al. Worries and needs of adults and parents of adults with neurofibromatosis type 1. Am J Med Genet A 2018;176:1150\u201360.","journal-title":"Am J Med Genet A"},{"key":"1404_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/ajmg.a.35720","volume":"161a","author":"C Cesaretti","year":"2013","unstructured":"Cesaretti C, Melloni G, Quagliarini D, Fogliani R, Zaina B, Bedeschi MF, et al. Neurofibromatosis type 1 and pregnancy: maternal complications and attitudes about prenatal diagnosis. Am J Med Genet A 2013;161a:386\u20138.","journal-title":"Am J Med Genet A"},{"key":"1404_CR11","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/1097-0223(200009)20:9<719::AID-PD895>3.0.CO;2-X","volume":"20","author":"P Origone","year":"2000","unstructured":"Origone P, Bonioli E, Panucci E, Costabel S, Ajmar F, Coviello DA. The Genoa experience of prenatal diagnosis in NF1. Prenat Diagn. 2000;20:719\u201324.","journal-title":"Prenat Diagn"},{"key":"1404_CR12","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/jgc4.1303","volume":"29","author":"HB Radtke","year":"2020","unstructured":"Radtke HB, Bergner AL, Goetsch AL, McGowan C, Panzer K, Cannon A. Genetic Counseling for Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis-Practice Resource of the National Society of Genetic Counselors. J Genet Couns. 2020;29:692\u2013714.","journal-title":"J Genet Couns"},{"key":"1404_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1399-0004.2009.01273.x","volume":"76","author":"JP Geraedts","year":"2009","unstructured":"Geraedts JP, De Wert GM. Preimplantation genetic diagnosis. Clin Genet. 2009;76:315\u201325.","journal-title":"Clin Genet"},{"key":"1404_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/pd.5662","volume":"40","author":"T Hardy","year":"2020","unstructured":"Hardy T. The role of prenatal diagnosis following preimplantation genetic testing for single-gene conditions: a historical overview of evolving technologies and clinical practice. Prenat Diagn. 2020;40:647\u201351.","journal-title":"Prenat Diagn"},{"key":"1404_CR15","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/humrep\/den488","volume":"24","author":"L Wilton","year":"2009","unstructured":"Wilton L, Thornhill A, Traeger-Synodinos J, Sermon KD, Harper JC. The causes of misdiagnosis and adverse outcomes in PGD. Hum Reprod. 2009;24:1221\u20138.","journal-title":"Hum Reprod"},{"key":"1404_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/humrep\/deh579","volume":"20","author":"AR Thornhill","year":"2005","unstructured":"Thornhill AR, deDie-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, et al. ESHRE PGD Consortium \u2018Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)\u2019. Hum Reprod. 2005;20:35\u201348.","journal-title":"Hum Reprod"},{"key":"1404_CR17","doi-asserted-by":"publisher","first-page":"hoaa021","DOI":"10.1093\/hropen\/hoaa021","volume":"2020","author":"F Carvalho","year":"2020","unstructured":"Carvalho F, Coonen E, Goossens V, Kokkali G, Rubio C, Meijer-Hoogeveen M, et al. ESHRE PGT Consortium good practice recommendations for the organisation of PGT. Hum Reprod Open. 2020;2020:hoaa021.","journal-title":"Hum Reprod Open"},{"key":"1404_CR18","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/humrep\/del064","volume":"21","author":"G Altarescu","year":"2006","unstructured":"Altarescu G, Brooks B, Kaplan Y, Eldar-Geva T, Margalioth EJ, Levy-Lahad E, et al. Single-sperm analysis for haplotype construction of de-novo paternal mutations: application to PGD for neurofibromatosis type 1. Hum Reprod. 2006;21:2047\u201351.","journal-title":"Hum Reprod"},{"key":"1404_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/pd.4874","volume":"36","author":"RP Naja","year":"2016","unstructured":"Naja RP, Dhanjal S, Doshi A, Serhal P, Delhanty J, SenGupta SB. The impact of mosaicism in preimplantation genetic diagnosis (PGD): approaches to PGD for dominant disorders in couples without family history. Prenat Diagn. 2016;36:864\u201370.","journal-title":"Prenat Diagn"},{"key":"1404_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/molehr\/gah170","volume":"11","author":"C Spits","year":"2005","unstructured":"Spits C, De Rycke M, Van Ranst N, Joris H, Verpoest W, Lissens W, et al. Preimplantation genetic diagnosis for neurofibromatosis type 1. Mol Hum Reprod. 2005;11:381\u20137.","journal-title":"Mol Hum Reprod"},{"key":"1404_CR21","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/humrep\/dep034","volume":"24","author":"E Vanneste","year":"2009","unstructured":"Vanneste E, Melotte C, Debrock S, D\u2019Hooghe T, Brems H, Fryns JP, et al. Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions. Hum Reprod. 2009;24:1522\u20138.","journal-title":"Hum Reprod"},{"key":"1404_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.tjog.2011.01.040","volume":"50","author":"YL Chen","year":"2011","unstructured":"Chen YL, Hung CC, Lin SY, Fang MY, Tsai YY, Chang LJ, et al. Successful application of the strategy of blastocyst biopsy, vitrification, whole genome amplification, and thawed embryo transfer for preimplantation genetic diagnosis of neurofibromatosis type 1. Taiwan J Obstet Gynecol. 2011;50:74\u20138.","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1404_CR23","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1472-6483(10)61809-3","volume":"4","author":"Y Verlinsky","year":"2002","unstructured":"Verlinsky Y, Rechitsky S, Verlinsky O, Chistokhina A, Sharapova T, Masciangelo C, et al. Preimplantation diagnosis for neurofibromatosis. Reprod Biomed Online. 2002;4:218\u201322.","journal-title":"Reprod Biomed Online"},{"key":"1404_CR24","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.fertnstert.2014.11.021","volume":"103","author":"VL Merker","year":"2015","unstructured":"Merker VL, Murphy TP, Hughes JB, Muzikansky A, Hughes MR, Souter I, et al. Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1. Fertil Steril. 2015;103:761\u20138.e1.","journal-title":"Fertil Steril"},{"key":"1404_CR25","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/ajmg.a.38372","volume":"173","author":"J Leppavirta","year":"2017","unstructured":"Leppavirta J, Kallionpaa RA, Uusitalo E, Vahlberg T, Poyhonen M, Timonen S, et al. The pregnancy in neurofibromatosis 1: a retrospective register-based total population study. Am J Med Genet A 2017;173:2641\u20138.","journal-title":"Am J Med Genet A"},{"key":"1404_CR26","doi-asserted-by":"publisher","first-page":"46.e1","DOI":"10.1016\/j.ajog.2013.03.029","volume":"209","author":"AR Terry","year":"2013","unstructured":"Terry AR, Barker FG 2nd, Leffert L, Bateman BT, Souter I, Plotkin SR. Neurofibromatosis type 1 and pregnancy complications: a population-based study. Am J Obstet Gynecol. 2013;209:46.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"1404_CR27","doi-asserted-by":"crossref","unstructured":"Kenborg L, Boschini C, Bidstrup PE, Dalton SO, Doser K, Nielsen TT, et al. Pregnancy outcomes in women with neurofibromatosis 1: a Danish population-based cohort study. J Med Genet. 2021;59:237\u201342.","DOI":"10.1136\/jmedgenet-2020-107201"},{"key":"1404_CR28","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/humrep\/dez106","volume":"34","author":"H Masset","year":"2019","unstructured":"Masset H, Zamani Esteki M, Dimitriadou E, Dreesen J, Debrock S, Derhaag J, et al. Multi-centre evaluation of a comprehensive preimplantation genetic test through haplotyping-by-sequencing. Hum Reprod. 2019;34:1608\u201319.","journal-title":"Hum Reprod"},{"key":"1404_CR29","doi-asserted-by":"crossref","unstructured":"van Dijk W, Derks K, Dr\u00fcsedau M, Meekels J, Koeck R, Essers R, et al. Embryo tracking system for high-throughput sequencing-based preimplantation genetic testing. Hum Reprod. 2022;37:2700\u201308.","DOI":"10.1093\/humrep\/deac208"},{"key":"1404_CR30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajhg.2015.04.011","volume":"96","author":"M Zamani Esteki","year":"2015","unstructured":"Zamani Esteki M, Dimitriadou E, Mateiu L, Melotte C, Van der Aa N, Kumar P, et al. Concurrent whole-genome haplotyping and copy-number profiling of single cells. Am J Hum Genet. 2015;96:894\u2013912.","journal-title":"Am J Hum Genet"},{"key":"1404_CR31","doi-asserted-by":"publisher","first-page":"hoaa018","DOI":"10.1093\/hropen\/hoaa018","volume":"2020","author":"F Carvalho","year":"2020","unstructured":"Carvalho F, Moutou C, Dimitriadou E, Dreesen J, Gim\u00e9nez C, Goossens V, et al. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders. Hum Reprod Open. 2020;2020:hoaa018.","journal-title":"Hum Reprod Open"},{"key":"1404_CR32","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/humrep\/dex265","volume":"32","author":"M De Rycke","year":"2017","unstructured":"De Rycke M, Goossens V, Kokkali G, Meijer-Hoogeveen M, Coonen E, Moutou C, et al. Consortium data collection XIV-XV: cycles from January 2011 to December 2012 with pregnancy follow-up to October 2013. Hum Reprod. 2017;32:1974\u201394.","journal-title":"Hum Reprod"},{"key":"1404_CR33","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1093\/humrep\/dez027","volume":"34","author":"V Berckmoes","year":"2019","unstructured":"Berckmoes V, Verdyck P, De Becker P, De Vos A, Verheyen G, Van der Niepen P, et al. Factors influencing the clinical outcome of preimplantation genetic testing for polycystic kidney disease. Hum Reprod. 2019;34:949\u201358.","journal-title":"Hum Reprod"},{"key":"1404_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/cge.12089","volume":"85","author":"MC van Rij","year":"2014","unstructured":"van Rij MC, de Koning Gans PA, van Belzen MJ, Roos RA, Geraedts JP, De Rademaeker M, et al. The uptake and outcome of prenatal and pre-implantation genetic diagnosis for Huntington\u2019s disease in the Netherlands (1998\u20132008). Clin Genet. 2014;85:87\u201395.","journal-title":"Clin Genet"},{"key":"1404_CR35","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ejhg.2011.202","volume":"20","author":"MC Van Rij","year":"2012","unstructured":"Van Rij MC, De Rademaeker M, Moutou C, Dreesen JC, De Rycke M, Liebaers I, et al. Preimplantation genetic diagnosis (PGD) for Huntington\u2019s disease: the experience of three European centres. Eur J Hum Genet. 2012;20:368\u201375.","journal-title":"Eur J Hum Genet"},{"key":"1404_CR36","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2215\/CJN.03550320","volume":"15","author":"R Snoek","year":"2020","unstructured":"Snoek R, Stokman MF, Lichtenbelt KD, van Tilborg TC, Simcox CE, Paulussen ADC, et al. Preimplantation genetic testing for monogenic kidney disease. Clin J Am Soc Nephrol. 2020;15:1279\u201386.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1404_CR37","doi-asserted-by":"crossref","unstructured":"Severijns Y, de Die-Smulders CEM, G\u00fcltzow T, de Vries H, van Osch L. Hereditary diseases and child wish: exploring motives, considerations, and the (joint) decision-making process of genetically at-risk couples. J Community Genet. 2021;12:325\u201335.","DOI":"10.1007\/s12687-021-00510-x"},{"key":"1404_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1601-5223.1988.tb00297.x","volume":"108","author":"B Samuelsson","year":"1988","unstructured":"Samuelsson B, Akesson HO. Relative fertility and mutation rate in neurofibromatosis. Hereditas 1988;108:169\u201371.","journal-title":"Hereditas"},{"key":"1404_CR39","doi-asserted-by":"publisher","first-page":"e0208835","DOI":"10.1371\/journal.pone.0208835","volume":"13","author":"H Chohan","year":"2018","unstructured":"Chohan H, Esfandiarei M, Arman D, Van Raamsdonk CD, van Breemen C, Friedman JM, et al. Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1. PLoS ONE. 2018;13:e0208835.","journal-title":"PLoS ONE"},{"key":"1404_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","volume":"8","author":"A Delvigne","year":"2002","unstructured":"Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8:559\u201377.","journal-title":"Hum Reprod Update"},{"key":"1404_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","volume":"170","author":"E Abalos","year":"2013","unstructured":"Abalos E, Cuesta C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170:1\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1404_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-0029-1236439","volume":"27","author":"A Kellogg","year":"2010","unstructured":"Kellogg A, Watson WJ. Malignant schwannoma in pregnancy: a case report and literature review. Am J Perinatol. 2010;27:201\u20134.","journal-title":"Am J Perinatol"},{"key":"1404_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/AOG.0b013e3181da0113","volume":"116","author":"DB Nelson","year":"2010","unstructured":"Nelson DB, Greer L, Wendel G. Neurofibromatosis and pregnancy: a report of maternal cardiopulmonary compromise. Obstet Gynecol. 2010;116:507\u20139.","journal-title":"Obstet Gynecol"},{"key":"1404_CR44","first-page":"530","volume":"110","author":"E Posma","year":"2003","unstructured":"Posma E, Aalbers R, Kurniawan YS, van Essen AJ, Peeters PM, van Loon AJ. Neurofibromatosis type I and pregnancy: a fatal attraction? Development of malignant schwannoma during pregnancy in a patient with neurofibromatosis type I. Bjog 2003;110:530\u20132.","journal-title":"Bjog"},{"key":"1404_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s004040100239","volume":"267","author":"M Isikoglu","year":"2002","unstructured":"Isikoglu M, Has R, Korkmaz D, Bebek N. Plexiform neurofibroma during and after pregnancy. Arch Gynecol Obstet. 2002;267:41\u20132.","journal-title":"Arch Gynecol Obstet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01404-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01404-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T23:04:35Z","timestamp":1691103875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-023-01404-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1404"],"URL":"https:\/\/doi.org\/10.1038\/s41431-023-01404-x","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"23 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MZE is an inventor on patent application ZL913096-PCT\/EP2014\/068315-WO\/2015\/028576, \u2018Haplotyping and copy-number typing using polymorphic variant allelic frequencies\u2019. The other authors have no conflict of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Medical and Ethical Review Committee of Maastricht University Medical Center+ (2018\u20130458). For all couples proceeding with PGT, written consent for using anonymized data for scientific purposes was retrieved as part of the PGT procedure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}